参考文献/References:
[1] Higa T,Maetani S,Yoichiro K,et al.T1-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas.Clin Nucl Med,2001,26(2):119-124.
[2] Semba T,Sugawara Y,Ochi T,et al.Thallium-201 SPECT in prognostic assessment of malignant gliomas treated with postoperative radiotherapy.Ann Nucl Med,2006,20(4):287-294.
[3] Cheng X,Li YJ,Xu ZQ,et al.A meta-analysis of 99mTc-MIBI SPECT for detection of recurrent glioma after radiation therapy.J Clin Neurosci,2011,18(3):307-312.
[4] Henze M,Ozdemir-Sahin N,Hipp P,et al.Comparison of diagnostic accuracy of (18) F-FDG PET,(123) I-IMT-and (99m) Tc-MIBI SPECT:evaluation of tumour progression in irradiated low grade astrocytomas.Nuklearmedizin,2006,45(1):49-56.
[5] Hellwig D,Kettcr R,Romeike BF,et al.Prospective study of p-[123I] iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions:specific confirmation of glioma.Eur J Nucl Med Mol Imaging,2010,37(12):2344-2353.
[6] 乔文礼,赵晋华,邵晓霞,等.131I-BmK CT的制备及其在胶质瘤荷瘤大鼠体内分布与显像研究.核技术,2011,34(3):213-216.
[7] Zhao JH,Qiao WL,Zhang Y,et al.Preparation and in vitro evaluation of 131I-BmK CT as a glioma-targeted agent.Cancer Biother Radiopharm,2010,25(3):353-359.
[8] Cher LM,Murone C,Lawrentschuk N,et al.Correlation of hypoxic cell fraction and angiogenesis with glucosc metabolic rate in gliomas using 18F-fluommisonidazole,18F-FDG PET,and immuno-histochemical studies.J Nucl Med,2006,47(3):410-418.
[9] Pirotte BJ,Lubansu A,Massager N,et al.Results of pesitmn emis-sion tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors.J Neurosurg,2007,107 Suppl5:392-399.
[10] 李伟龙.大鼠C6胶质瘤放射治疗前后18F-FDG PET/CT显像及病理学变化.放射学实践,2011,26(5):479-482.
[11] Padma MV,Said S,Jacobs M,et al.Prediction of pathology and survival by FDG PET in gliomas.J Neurooncol,2003,64(3):227-237.
[12] Spence AM,Muzi M,Mankoff DA,et al.18F-FDG PET of gliomas at delayed intervals:improved distinction between tumor and normal gray matter.J Nucl Med,2004,45(10):1653-1659.
[13] Kracht LW,Friese M,Herholz K,et al.Methyl-[11C]-I-methionine uptake as measured by positron emission tomography correlates to micmvessel density in patients with glioma.Eur J Nucl Med Mol Imaging,2003,30(6):868-873.
[14] 邵虹,Trampal C,吴靖川.11C-蛋氨酸PET显像诊断胶质瘤的价值.中华核医学杂志,2003,23(2):75-76.
[15] 胡裕效,朱虹.11C-MET PET显像在脑胶质瘤中的应用进展.放射学实践,2010,25(11):1293-1295.
[16] 理东丽,许乙凯,王全师,等.11C.MET和18F-FDG PET/CT对胶质瘤诊断的价值比较.核技术,2011,34(2):151-154.
[17] Weber WA,Wester HJ,Grosu AL,et al.O-(2.[18F] fluoroethyl)-L-tyrosine and L-[methyl-11C] methionine uptake in brain turnouts:initial results of a comparative study.Eur J Nucl Med,2000,27(5):542-549.
[18] Popperl G,Kreth FW,Mehrkens JH,et al.FET PET for the evaluation of untreated gliomas:correlation of FET uptake and uptake kinetics with tumor grading.Eur J Nucl Med Mol Imaging,2007,34(12):1933-1942.
[19] Plotkin M,Blechschmidt C,Auf G,et al.Comparison of F-18 FET PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.Eur Radiol,2010,20(10):2496-2502.
[20] Floeth FW,Pauleit D,Sabel M,et al.Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.J Nucl Med,2007,48(4):519-527.
[21] Hutterer M,Nowosielski M,Putzer D,et al.O-(2-18F-Fluomethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.J Nucl Med,2011,52(6):856-864.
[22] Mehrkens JH,Pöpperl G,Rachinger W,et al.The positive predic-tive value of O-(2-[18F] fluoroethyl)-L-tymsine (FET) PET in the diag-nosis of a glioma recurrence after muhimodal treatment.J Neuroon-col,2008,88(1):27-35.
[23] 李方明,聂青,赵文锐,等.CHO PET功能显像:脑胶质瘤诊断和优化放化疗方案.中华神经外科疾病研究杂志,2011,10(2):154-157.
[24] Hatakeyama T,Kawai N,Nishiyama Y,et al.11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.Eur J Nucl Med Mol Imaging,2008,35(11):2009-2017.
[25] Tripathi M,Sharma R,D’Souza M,et al.Comparative evaluation of F-18 FDOPA,F-18 FDG,and F-18 FLT PET/CT for metabolic imaging of low grade gliomas.Clin Nucl Med,2009,34(12):878-883.
[26] Sehiepers C,Dahlbom M,Chen W,et al.Kinetics of 3’-deoxy-3’-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.J Nuel Med,2010,51(5):720-727.
[27] Rueger MA,Ameli M,Li H,et al.[18F] FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas.Mol Imaging Biol,2011,13(3):547-557.
[28] Swanson KR,Chakraborty G,Wang CH,et al.Complementary bat distinct roles for MRI and 18F-fluommisonidazole PET in the assess-ment of human glioblastomas.J Nucl Med,2009,50(1):36-44.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]周惠君,董萍,沈国华,等.11C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值[J].国际放射医学核医学杂志,2015,39(2):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
Zhou Huijun,Dong Ping,Shen Guohua,et al.Value of 11C-methionine PET/CT imaging indiagnosing cerebral glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
[12]展凤麟,汪世存,潘博,等.11C-胆碱和18F-FDG PET/CT显像在脑胶质瘤诊断中的应用[J].国际放射医学核医学杂志,2013,37(4):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
ZHAN Feng-lin,WANG Shi-cun,PAN Bo,et al.Application of 11C-choline and 18F-FDG PET/CT in diagnosing brain glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
[13]乐亚丽,陈跃.多种不同PET或PET/CT分子探针在胶质瘤中的应用进展[J].国际放射医学核医学杂志,2013,37(6):364.[doi:10.3760/cma.j.issn.1673-4114.2013.06.010]
LE Ya-li,CHEN Yue.Progress on application of different PET or PET/CT agents in glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):364.[doi:10.3760/cma.j.issn.1673-4114.2013.06.010]
[14]胡晓云,胡春洪,方向明,等.脑胶质瘤的11C-甲硫氨酸和11C-胆碱PET和PET-CT[J].国际放射医学核医学杂志,2008,32(1):20.
HU Xiao-yun,HU Chun-hong,FANG Xiang-ming,et al.The application of 11C-methionine and 11C-choline in PET and PET-CT for cerebral gliomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):20.